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Abstract Staphylococcus aureus is a leading cause of blood-
stream infections (BSI) and diseases that may be caused by
hematogenous spread. The staphylococcal adhesin, for which
the association with the infections emerging as a complication
of septicemia has been well documented, is a bone
sialoprotein-binding protein (Bbp). The aim of the study was
to assess the prevalence of a bbp gene in S. aureus blood-
stream isolates associated with BSI and to investigate to what
degree the distribution of this gene is linked to the clonality of
the population. Spa typing, used in order to explore the genetic
population structure of the isolates, yielded 29 types. Six spa
clusters and seven singletons were identified. The most fre-
quent was spa clonal complex CC021 associated with MLST
CC30 (38 %). The bbp gene was found in 47 % of isolates.
Almost all isolates (95 %) clustered in spa clonal complex
CC021 were positive for this gene. All isolates carrying the
bbp gene were sensitive to methicillin, and if clustered in the
spa CC021, belonged to agr group III. Our study shows that
Bbp is not strictly associated with BSI. However, one may
conclude that for clonally related S. aureus strains most com-
monly causing BSI, the risk of Bbp-mediated complications
of septicemia is expected to be higher than for other strains.
Introduction
Staphylococcus aureus is a leading cause of bloodstream
infections (BSI) (Grundmann et al. 2010). Hospital BSIs
caused by this bacterium are associated with significant mor-
bidity and mortality, particularly in populations at high risk of
infection. An early and critical step in establishing BSI pro-
cess is bacterial adhesion and colonization of host tissues
(Naber 2009). In S. aureus, surface proteins interacting with
host molecules were named Microbial Surface Components
Recognizing Adhesive Matrix Molecules (MSCRAMMs)
(Patti and Höök 1994). The relationship between the tissue
tropism and the expression of particular MSCRAMMs is still
insufficiently cleared but the adhesin, for which the
association with the infections emerging as a complication
of septicemia has been well documented, is a bone
sialoprotein-binding protein (Bbp) (Cunningham et al. 1996;
Rydén et al. 1987, 1989). Moreover, there is evidence that the
role of Bbp can be broader than that of a simple tissue tropism
(Persson et al. 2009; Vazquez et al. 2011).
The Bbp interacts with bone sialoprotein (BSP), an essen-
tial component of bone and dentine extracellular matrix
(Yacoub et al. 1994). It is possible that Bbp may function in
two capacities: as an important factor in the colonization of
bone tissue and as a contributing factor in S. aureus hemato-
logic diseases (Berendt and Byren 2004). In an in vivo animal
model, BSP binding capacity was found in all staphylococci-
producing septic arthritis (Bremell et al. 1991). Moreover, the
serum from patients suffering from bone and joint infection
contained antibodies that reacted with the fusion protein of the
BSP-binding protein, indicating that the protein is expressed
during an infection and is immunogenic (Persson et al. 2009).
The study of Vazquez et al. (2011) showed that human fibrin-
ogen is also a ligand for Bbp which can manipulate the
biology of the fibrinogen in the host (Vazquez et al. 2011).
Thus, a specificity of Bbp for a factor other than BSP cannot
be excluded.
The diseases preferentially associated with Bbp are osteo-
myelitis and septic arthritis (Bremell et al. 1991; Rydén et al.
1987, 1997). The presence of bbp gene encoding for Bbp in S.
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aureus-caused orthopedic implant infections has been de-
scribed (Campoccia et al. 2009). Moreover, co-existence of
bbp and collagen-binding protein (cna) gene in such isolates
suggests that these two adhesins may act together in the
implant infections (Campoccia et al. 2009). The combination
of the bbp and cna genes was also found in the pandemic type
of community-acquired methicillin-resistant S. aureus (CA-
MRSA) (Arnold et al. 2006). According to evidence, the
expression of S. aureus bbp gene may correlate with genes
for methicillin-resistance and Panton-Valentine leukocidin
(PVL) (Otsuka et al. 2006; Witte et al. 2005). The association
between the accessory gene regulator (agr) system and bbp
presence in S. aureus has also been described (Montanaro
et al. 2010).
The species S. aureus has a highly clonal population struc-
ture (Feil et al. 2003) but the frequency of Bbp in S. aureus
isolates causing bacteremia has not been well documented.
Moreover, the diseases associated with Bbp may be a compli-
cation of septicemia as the staphylococci reach a bone or joint
region via the bloodstream. For this reason, the aim of the
present study was to assess the prevalence of the bbp gene in
S. aureus isolates associated with BSI and to investigate to
what degree the distribution of this gene is linked to the
clonality of the population.
Materials and methods
Bacterial isolates
The study was performed on 53S. aureus bloodstream isolates
obtained from patients of 19 departments of the University
Clinical Center (UCC) in Gdańsk, including the following:
cardiology (12); nefrology, transplantology, and internal med-
icine—NTIM (6); hematology (4); internal medicine, endo-
crinology, and homeostasis disturbances—IMEHD (4);
gastrohepatology (3); hypertension and diabetology (3); adult
neurology (3); intensive care unit—ICU (3); oncology and
radiology (2); internal medicine and intoxications—IMI (2);
isolation unit (2); cardiac surgery; hypertension, internal med-
icine, hemodialysis, and transplant medicine—HIMHTM;
venerology and allergology; rehabilitation; pediatric
nefrology; pediatric oncology, hematology and endocrinolo-
gy—POHE; neurological surgery (1 each); not classified (2).
All the patients were considered to have true bloodstream
infection defined as at least one blood culture positive for
S. aureus during the presence of the systemic inflammatory
response syndrome. The additional data about clinical recog-
nitions and risk factors associated with BSI in individual
patients were not available. The strains were isolated in the
UCC laboratory fromMarch 2008 toMarch 2009 (13 months)
and sent to the Microbiology Department of the Medical
University of Gdańsk for further analyses. The first isolate
from patient was included in the study. The bacteria were
cultured on sheep blood agar (Oxoid, UK) and were re-
identified by API ID32 Staph system (Bio Mérieux, France).
For further purposes, the isolates were subcultured on nutrient
broth and stored in glycerol at −70 °C.
Bacterial DNA isolation
Genomic DNA used as an amplification template was extract-
ed from the bacterial cultures using Gene MATRIX Bacterial
& Yeast Genomic DNA Purification Kit (EURx Ltd., Poland)
according to the manufacturer’s instruction.
Antimicrobial drug susceptibility testing
Resistance to methicillin was primary tested using disc diffu-
sion method on Mueller Hinton agar (Oxoid, UK), with oxa-
cillin and cefoxitin discs (Becton Dickinson, Germany) and
confirmed by the detection ofmecA gene by polymerase chain
reaction (PCR) (Barski et al. 1996). The susceptibility to
antimicrobial agents was determined by the disc diffusion
method according to recommendations given by Hryniewicz
et al. (2005) and the CLSI guidelines (2006). The antibiotics
tested were the following: penicillin, erythromycin,
clindamycin, ciprofloxacin, co-trimoxazole, tetracycline, gen-
tamicin, vancomycin, teicoplanin, fusidic acid, rifampicin,
linezolid, quinupristin-dalfopristin, chloramphenicol (Becton
Dickinson, Germany), and mupirocin (Oxoid, UK). For all the
isolates beta-lactamase production was checked by nitrocefin
test (Becton Dickinson, Germany). For isolates identified as
resistant to erythromycin, but susceptible to clindamycin, D-
test was performed to detect inducible clindamycin resistance
(Fiebelkorn et al. 2003). The susceptibility to vancomycin was
confirmed by the minimal inhibitory concentration (MIC)
using E-tests, as described by the manufacturer (AB Biodisc,
Sweden).
Detection of bbp and cna genes
Detection of bbp and cna genes was performed by PCR. The
nucleotide sequence of the primers and thermal cycling con-
ditions were described by Tristan et al. (2003).
Detection of PVL genes
All the isolates were screened for the presence of lukS-PVand
lukF-PV genes by PCR as described by Lina et al. (1999).
Spa typing and based upon repeat pattern analysis
The polymorphic X region of the protein A gene (spa) was
amplified from the isolates by PCR according to the procedure
described by Harmsen et al. (2003). Spa types were
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determined by using Ridom Staph Type software (Harmsen
et al. 2003). The spa types were clustered into spaCCs (clonal
complexes) using the algorithm based upon repeat pattern
(BURP) (Rupptisch et al. 2006).
Determination of MLST clonal complexes
Since spa typing, together with the algorithm BURP, and
multilocus sequence typing (MLST) are highly concordant
(Enright et al. 2000; Strommenger et al. 2008), the associated
MLST CCs were allocated through the Ridom SpaServer
database (www.spaserver.ridom.de).
Agr typing
The agr group-specific multiplex PCR was performed with
the use of primers and thermal cycling conditions described
previously (Shopsin et al. 2003).
SCCmec typing
Typing of the staphylococcal chromosomal cassette (SCC)
mec was done in MRSA isolates as described previously
(Milheiriço et al. 2007).
Results
The results of the current bbp gene research, in relation to spa
typing and clonal complexes analysis, are provided in Table 1.
Spa–typing yielded 29 types. BURP analysis of the spa types
identified six clusters and seven singletons. The most frequent
was spa CC021, associated with MLST CC30, harboring
38 % of the isolates. Within the spa CC021, consisted of nine
types, the most common was t021 (7/20=35 %). The second
frequent was singleton represented by 13 % of the isolates,
with only one spa type t127 related to MLST CC1. The third
one was spa CC085 (9%) consisted of three types: t084, t085,
t355 associated withMLSTCC15. The bbp genewas found in
47 % of the isolates. Most of the isolates positive for bbp
belonged to the spa CC021 (76 %). The bbp gene occurred in
19/20 isolates of this cluster (95 %). The remaining isolates
carrying the bbp gene were included in a cluster without the
primary founder of a group (t645 and t4495), associated with
MLST CC121, or in spa CC775 related to MLST CC25 (t056
and t775). One isolate with spa repeat pattern uncorrelated
with other types was also positive for bbp. No one isolate
belonging to the most frequent singleton or to the spa CC085
carried the bbp gene.
Table 2 shows that in the total studied population only three
isolates (6 %) were resistant to methicillin. The MRSA iso-
lates were identified as t032/SccmecIV, t008/SccmecIV, and
t003/SccmecII (shown in footnote below the table). None of
the MRSA isolates were positive for bbp, whereas 3/7 of the
PVL-positive isolates carried the bbp gene. The cna gene was
detected in 33/53 isolates (62 %) of which 19 (58 %) also
carried bbp. The agr polymorphism study revealed that the
most frequent were the agr types III (29/53=55 %) and I (14/
53=26%). The bbp gene possessed 69% of the isolates of the
agr group III, 14% of the isolates of the agr group I and all the
isolates of the agr group IV. No isolate belonging to the agr
group II was positive for bbp.
The subpopulation of isolates positive for bbp was de-
scribed in Table 3. According to our data, such isolates were
distributed in 16 departments and were constantly present in
the UCC throughout the observed period. The bbp positive
isolates were obtained with the highest frequency from pa-
tients of the cardiology (16 %) and the nefrology,
transplantology, and internal medicine department (12 %).
Almost all isolates with the bbp gene (92 %) were resistant
to penicillin. All penicillin-resistant isolates produced beta-
lactamase (data not shown). Resistance to penicillin only was
observed in 56 % of isolates, in terms of the spa CC021 and
one of the clusters without the primary founder of a group. In
five isolates (20 %) exhibiting penicillin resistance, additional
resistance to macrolides, inducible or constitutive, was ob-
served. Three isolates (12 %), including two belonging to the
spa CC775/agr type I and one to CC021, were sensitive to all
the antibiotics. Only one isolate was resistant to penicillin,
macrolides, ciprofloxacin, tetracycline, and chloramphenicol.
The isolates harboring the bbp gene belonged to agr group III
in 84 % were positive for cna gene in 88 % and for PVL in
12 %. None of the isolates belonging to the spa CC021
harbored the PVL gene.
Discussion
In the first step of our investigations, we focused on molecular
characterization of the S. aureus isolates associated with BSI.
In order to explore the genetic population structure of the
isolates, we used spa genotyping as a method with both a
high discriminatory power and results that can be easily
compared between laboratories (Strommenger et al. 2008).
Spa typing is based on the variation of the polymorphic region
within the staphylococcal protein A gene (Harmsen et al.
2003). There is a high concordance between spa typing and
other genotyping methods, including MLST (Enright et al.
2000; Strommenger et al. 2008). Thus, we analyzed the results
considering the relationship to MLST clones described in
database.
Looking at the clonal structure of the isolates, our results
confirm several major findings of previously published sur-
veys (Fenner et al. 2003; Grundmann et al. 2010; Nulens et al.
2008). The most frequent in our collection was spa CC021
related to MLST CC30, with the main spa type t021.
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According to the data obtained by international multicenter
trials, t021 belongs to the 20 most frequent spa types among
S. aureus isolates causing invasive infections in Europe
(Grundmann et al. 2010). We confirmed findings of a study
on local population of S. aureus in Eastern Pomerania, Poland,
where within CC30, the t021 dominated the bloodstream
isolates (Holtfreter et al. 2007). But, interestingly, in that
study, CC30 was significantly more common among nasal
strains than among blood culture isolates. It could mean that
CC30 is widely disseminated among Polish S. aureus strains
population in general. In contrast, in other European countries,
CC30 is reported as more prevalent in invasive strains than in
noninvasive (Wertheim et al. 2005). For example, spa types
corresponding with CC30 were observed in invasive MSSA
in a Swiss University Hospital (Fenner et al. 2003) and in
bloodstream isolates collected from a Dutch University Hos-
pital (Nulens et al. 2008). The more recent study fromNorway
showed that CC30 was the most frequent clonal complex in
MSSA isolates from deep surgical site infections in orthopedic
patients (Aamot et al. 2012). However, there were some
differences, when comparing our results to data published by
others. The t002/ST-5 and t084/ST-15 were described as the
Table 1 Occurrence of the bone sialoprotein-binding protein gene in S. aureus bloodstream isolates, in relation to spa types and clonal complexes










CC021 20 (38 ) 9 t021(7); t012 (3); t12362 (3);





CC085 5 (9) 3 t084 (3); t085 (1); t335 (1) 15
CC775 4 (8) 3 t078 (2); t056 (1); t775 (1) 2 (8) 25
No founder #4 4 (8) 2 t015 (3); t050 (1) 45
No founder #5 3 (6) 2 t645 (2); t4495 (1) 3 (12) 121
No founder #6 3 (6) 3 t005 (1); t032 (1); t310 (1) 22
Singleton #1 2 (4) 1 t008 (2) 8
Singleton #2 7 (13) 1 t127 (7) 1
Singleton #3 1 (2) 1 t148 (1) 72
Singleton #4 1 (2) 1 t164 (1) 20
Singleton #5 1 (2) 1 t1508 (1) –
Singleton #6 1 (2) 1 t003 (1) 5
Singleton #7 1 (2) 1 t9489 (1) 1 (4) –
Total 53 (100) 29 (100) – 25 (100) –
a CC, as allocated though the Ridom SpaServer database
Table 2 Occurrence of the bbp gene in 53 S. aureus bloodstream isolates with regard to methicillin-resistance and presence of selected virulence
associated determinants
Isolates Number (%) of isolates
MSSA MRSA PVL+ cna+ agr group
I II III IV
bbp+ 25 (50) 0 3 (43) 19 (58) 2 (14) 0 20 (69) 3 (100)
bbp− 25 (50) 3 (100)a 4 (57) 14 (42) 12 (86) 7 (100) 9 (31) 0
Total 50 (100) 3 (100) 7 (100) 33 (100) 14 (100) 7 (100) 29 (100) 3(100)
bbp bone sialoprotein-binding protein gene, PVL Panton-Valentine leukocidin toxin gene, cna collagen-binding protein gene, agr accessory gene regulator
a t032/Sccmec IV; t008/Sccmec IV; t003/Sccmec II
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first spa types among MSSA from invasive infections in
Europe in 2010. In Polish laboratories participating in that
study, the most prevalent among MSSA were t127/ST-1,
t084/ST-15, and t015/ST-45 (Grundmann et al. 2010). In our
collection, t127 was observed as frequently as t021 but with
no correlation to other spa types and t002 was not found at all.
The main conception of our study was to assess the prev-
alence of the bbp gene, in relation to the clonality of the
population described above. The results could mean that
Bbp is not strongly associated with BSI, as the gene for this
factor was found in almost half of the isolates. It may be not
surprising, since our strain collection was not restricted to
patients with selected risk factors for a particular location of
infection, as it has been described in the literature (Aamot
et al. 2012; Luedicke et al. 2010; Rydén et al. 1989). For
example, in the Aamot et al. study (2010) on MSSA isolates
from deep surgical site infections in orthopedic patients, 95 %
of the isolates from invasive diseases were positive for bbp.
Moreover, our investigations were not restricted to the
departments where, according to evidence, the bbp--
positive strains among S. aureus isolates were supposed
to occur with the highest frequency (Aamot et al. 2012).
But the findings of previously published investigations
on S. aureus strains associated with blood infections
were not consistent. For example, in the study of Tris-
tan et al. (2003), the bbp gene was strictly associated
with S. aureus strains involved in human hematogenous
infections. By contrast, in the Hogevik et al. report
(1998), no correlation was found between the potential
bacterial virulence factors, including Bbp and infective
endocarditis. What comes to our notice is that almost all
bbp positive isolates were clustered to the spa CC021,
corresponding to MLST CC30—the most widely dis-
seminated clonal complex among the S. aureus blood-
stream isolates from the UCC. It is interesting in view
of the hypothesis that CC30 causes systemic infections
Table 3 Characteristic of the bone sialoprotein-binding protein gene positive S. aureus bloodstream isolates
No. Date of isolation Department Antibiotic resistance Spa type spa-CC PVL cna agr group
1. 8.03 Cardiology Pe t021 CC021 – + III
2. 5.05. Cardiology Pe E CC t122 CC021 – + III
3. 9.05. Gastrohepatology Pe E Cc Cip Te C t645 Nf #5 – + IV
4. 19.05. Oncology and Radiology Pe E Cc/ t021 CC021 – + III
5. 26.05. Cardiac Surgery Pe t021 CC021 – + III
6. 28.05. NTIM Pe t4495 Nf #5 – + IV
7. 5.06. HIMHTM Pe t12362 CC021 – + III
8. 11.06. Hematology Pe t10689 CC021 – + III
9. 2.07. Isolation Unit Pe t021 CC021 – + III
10. 18.07 Cardiology ICU Pe t342 CC021 – + III
11. 2.10. Gastrohepatology Pe t645 Nf #5 + + III
12. 16.10. Oncology and Radiology Pe E Cc t012 CC021 – + III
13. 14.10. Intensive Therapy Pe Te t021 CC021 – + III
14. 9.11 Rehabilitation Pe Cip t012 CC021 – + III
15. 10.11 NTIM Pe t021 CC021 – + III
16. 27.11 NTIM Senistive t017 CC021 – + III
17. 29.11 Adult Neurology Pe E Te t12362 CC021 – + III
18. 25.12 IMEHD Pe E Cc/ t12362 CC021 – + III
19. 28.12 No data Pe t021 CC021 – – III
20. 10.01. Hematology Sensitive t056 CC775 + – I
21. 15.01 POHE Pe t1649 CC021 – + III
22. 27.01 Cardiology ICU Sensitive t775 CC775 + – I
23. 6.02 Neurosurgery Pe t342 CC021 – + III
24. 27.02 Adult Neurology Pe t9489 singleton – + III
25. 26.03 IMI Pe t012 CC021 – + III
NTIM nefrology, transplantology, and internal medicine,HIMHTM hypertension, internal medicine, hemodialysis, and transplant medicine, ICU intensive
care unit, IMEHED internal medicine, endocrinology, and homeostasis disturbances, POHE pediatric oncology, hematology and endocrinology, IMI
internal medicine and intoxications—as described in “Materials and methods” section; Pe penicillin, E erythromycin, Cc clindamycin, Cip ciprofloxacin,
Te tetracycline, / inducible clindamycin resistance,Nf no founder cluster, PVL Panton-Valentine leukocidin toxin gene, cna collagen-binding protein gene,
agr accessory gene regulator
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only under very accommodating conditions (Holtfreter
et al. 2007).
The production of toxins and surface proteins in S. aureus
is globally regulated by the agr system. Four allelic groups of
agr have been recognized in S. aureus (Novick et al. 1993).
Some epidemiological findings suggest that the particular agr
group can correspond to the genetic background in this bac-
terium andmay be associated with virulence profile suitable to
clinically specific infections (Montanaro et al. 2010). In our
study, the most frequently observed agr III group was gener-
ally associated with the presence of the bbp gene, whereas the
second one agr I was rather negative. Additionally, a few
isolates of agr IV showed full association with the bbp gene,
in contrast to agr II, fully negative for this gene. The similar
observation was done by Montanaro et al. (2010) in S. aureus
isolates from orthopedic implants infections. They showed
that agr III differed clearly from agr I and II, exhibiting high
prevalence of bbp, whereas agr I and II generally did not
harbor this gene. Moreover, the same authors described agr
II in such isolates as to be frequent in epidemic clones.
The association between the presence of bbp and cna
genes, similar to that found in S. aureus causing orthopedic
implant infections (Campoccia et al. 2009) was not observed
in our bloodstream isolates. The frequencies of the cna gene in
bbp-negative and bbp-positive isolates were similar. However,
most of the isolates carrying the bbp gene were positive for
cna. Thus, the conclusion that these two adhesins act together
in BSI may not be excluded. It is clear that the interactions of
S. aureus with host cells are complex.
The lack of the bbp gene in any MRSA strains may
be explained by relatively low prevalence of MRSA
among bloodstream isolates at the UCC in the study
period. Our earlier investigations, performed on MRSA
population in this hospital, revealed the predominance
of spa CC010 and spa types related to CA-MRSA
(Wiśniewska et al. 2012). The present study confirmed
that in the bloodstream collection isolates two spa types
associated with CA-MRSA: t008/SCCmecIV and t0032/
SccmecIV occurred, but both were negative for bbp.
Looking at the antibiotic resistance patterns of the bbp
positive strains, selective pressure of antibiotics which
may affect the frequency of this factor in the blood-
stream isolates seems to be unlikely. One of the
distinguishing features of CA-MRSA is that high per-
centage of such strains is positive for PVL (Witte et al.
2005). In our collection of bloodstream isolates, the
PVL gene occurred occasionally. Moreover, the frequen-
cy of this gene in bbp-positive subpopulation, versus
bbp-negative subpopulation, was similar. As a conse-
quence, an association could be excluded.
To sum up, our study shows that Bbp is not strictly asso-
ciated with BSI. However, from the results one may conclude
that for clonally related S. aureus strains most commonly
causing BSI, the risk of Bbp-mediated complications of sep-
ticemia is expected to be higher than for other strains. We
found the clonal complex widely distributed among invasive
S. aureus strains in Europe as to be strongly associated with
Bbp. In fact, the high frequency of the bbp gene in the most
prevalent clone could mean that Bbp contributes to the dis-
ease. Although, coincidental presence of this gene in the
clone, which is common for other reasons than the carriage,
may not be excluded (Aamot et al. 2012).
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
Aamot HV, Blomfeldt A, Skramm I et al (2012) Molecular characteriza-
tion of methicillin-sensitive Staphylococcus aureus from deep sur-
gical site infections in orthopaedic patients. Eur J Clin Microbiol
Infect Dis 31:1999–2004
Arnold SR, Elias D, Buckingham SC, Thomas ED, Novias E, Arkader A,
Howard C (2006) Changing patterns of acute hematogenous osteo-
myelitis and septic arthritis: emergence of community-associated
methicillin-resistant Staphylococcus aureus. J Pediatr Orthop 26:
703–708
Barski P, Piechowicz L, Galiński J et al (1996) Rapid assay for detection
of methicillin-resistant Staphylococcus aureus usingmultiplex PCR.
Molec Cell Probes 10:471–475
Berendt T, Byren I (2004) Bone and joint infection. Clin Med 4:510–518
Bremell T, Lange S, Yacoub A, Ryden C, Tarkowski A (1991)
Experimental Staphylococcus aureus arthritis in mice. Infect
Immun 59:2615–2623
Campoccia D, Speziale P, Ravaioli S et al (2009) The presence of both
bone sialoprotein-binding protein gene and collagen adhesin gene as
a typical virulence trait of the major epidemic cluster in isolates from
orthopedic implant infections. Biomaterials 30:6621–6628
CLSI: Clinical and Laboratory Standards Institute (2006) Performance
standards for antimicrobial susceptibility testing; sixteenth informa-
tional supplement. M100-S16. Vol. 26, No.3
Cunningham R, Cockayne A, Humphreys H (1996) Clinical and molec-
ular aspects of the pathogenesis of Staphylococcus aureus bone and
joint infections. J Med Microbiol 44(3):157–164
Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000)
Multilocus sequence typing for characterization of methicillin-
resistant and methicillin-susceptible clones of Staphylococcus
aureus. J Clin Microbiol 38(3):1008–1015
Feil EJ, Cooper JE, Grundmann H, Robinson DA, Enright MC, Berendt
T, Peacock SJ, Smith JM, Murphy M, Spratt BG, Moore CE, Day
NP (2003) How clonal is Staphylococcus aureus? J Bacteriol 185:
3307–3316
Fenner L, Widmer F, Frei R (2003) Molecular epidemiology of invasive
methicillin-susceptible Staphylococcus aureus strains circulating at
a Swiss University Hospital. Eur J Clin Microbiol Infect Dis 27:
623–626
Fiebelkorn KR, Crawford SA, Mc Elmeel ML et al (2003) Practical disc
diffusion method for detection of inducible clindamycin resistance
in Staphylococcus aureus and coagulase- negative staphylococci. J
Clin Microbiol 41:4740–4744
470 Folia Microbiol (2014) 59:465–471
Grundmann H, Aanensen DM, van den Wijngaard CC et al (2010)
Geographic distribution of Staphylococcus aureus causing invasive
infections in Europe: a molecular-epidemiological analysis. PLoS
Med 7(1):e1000215. doi:10.1371/journal.pmed.1000215, http//
www.plosmedicine.org/
Harmsen D, Claus H, Witte Wet al (2003) Typing of methicillin-resistant
Staphylococcus aureus in a university hospital setting by using
novel software for spa repeat determination and database manage-
ment. J Clin Microbiol 41:5442–5448
Hogevik H, S derquist B, Tung HS et al (1998) Virulence factors of
Staphylococcus aureus strains causing infective endocarditis—a
comparison with strains from skin infections. APMIS 106:901–908
Holtfreter S, Grumann D, Schmuldde M et al (2007) Clonal distribution
of superantigen genes in clinical Staphylococcus aureus isolates. J
Clin Microbiol 45:2669–2680
Hryniewicz W, Sulikowska A, Szczypa K et al (2005) Recommendations
for susceptibility testing to antimicrobial agents of selected bacterial
species. Post Mikrobiol 44:175–192
Lina G, Piémont I, Godail-Garnot F et al (1999) Involvement of Panton-
Valentine leukocidin—producing Staphylococcus aureus in primary
skin infections and pneumonia. Clin Infect Dis 29:1128–1132
Luedicke C, Slickers P, Ehricht R et al (2010) Molecular fingerprinting of
Staphylococcus aureus from bone and joint infections. Eur J Clin
Microbiol Infect Dis 29:457–463
Milheiriço C, Oliveira DC, de Lancastre H (2007)Update to the multiplex
PCR strategy for assignment of mec element types in
Staphylococcus aureus. Antimicrob Agents Chemother 51:3374–
3377
Montanaro L, Speziale P, Campoccia D et al (2010) Polymorphisms of
agr locus correspond to distinct genetic patterns of virulence in
Staphylococcus aureus clinical isolates from orthopedic implant
infections. J Biomed Mater Res 94A:825–832
Naber CK (2009) Staphylococcus aureus bacteremia: epidemiology,
pathophysiology and management strategies. Clin Infect Dis
48(4):231–237
Novick RP, Ross HF, Projan SJ et al (1993) Synthesis of staphylococcal
virulence factors is controlled by regulatory RNAmolecule. EMBO
J 12:3967–3975
Nulens E, Stobberingh EE, van Dessel H et al (2008) Molecular charac-
terization of Staphylococcus aureus bloodstream isolates collected
in a Dutch University Hospital between 1999 and 2006. J Clin
Microbiol 46:2438–2441
Otsuka T, Saito K, Dohmae S et al (2006) Key adhesion gene in
community-acquired methicillin-resistant Staphylococcus aureus.
Biochem Biophys Res Commun 346:1234–1244
Patti JM, Höök M (1994) Microbial adhesions recognizing extracellular
matrix macromolecules. Curr Opin Cell Biol 6:752–758
Persson L, Johansson C, Rydén C (2009) Antibodies to Staphylococcus
aureus bone sialoprotein-binding protein indicate infectious osteo-
myelitis. Clin Vaccine Immunol 16(6):949–952
Rupptisch W, Indra A, Stoger A et al (2006) Classifying spa
types in complexes improves interpretation of typing results
for methicillin-resistant Staphylococcus aureus. J Clin
Microbiol 44:2442–2448
Rydén C, Maxe I, Franzen A et al (1987) Selective binding of bone matrix
sialoprotein to Staphylococcus aureus in osteomyelitis. Lancet 2:515
Rydén C, Yacoub A, Maxe I et al (1989) Specific binding of bone
sialoprotein to Staphylococcus aureus isolated from patients with
osteomyelitis. Eur J Biochem 184:331–336
Rydén C, Tung HS, Nikolaev V et al (1997) Staphylococcus
aureus causing osteomyelitis binds to a nonapeptide sequence
in bone sialoprotein. Biochem J 327:825–829
Shopsin B, Mathema B, Alcabes P et al (2003) Prevalence of agr
specificity groups among Staphylococcus aureus strains colonizing
children and their guardians. J Clin Microbiol 41:456–459
Strommenger B, Braulke C, Heuck D et al (2008) Spa typing of
Staphylococcus aureus as a frontline tool in epidemiological typing.
J Clin Microbiol 46:574–581
Tristan AL, Ying MB, Etienne J, Vandenesch F, Lina G (2003) Use of
multiplex PCR to identify Staphylococcus aureus adhesions in-
volved in human hematogenous infections. J Clin Microbiol 41:
4465–4467
Vazquez V, Liang X, Horndahi JK et al (2011) Fibrinogen is a ligand for
the Staphylococcus aureus microbial surface components recogniz-
ing adhesive matrix molecules (MSCRAMM) bone sialoprotein-
binding protein (Bbp). J Biol Chem 286(34):29797–29805
Wertheim HF, vanLeeuwen WB, Snijders MC et al (2005)
Associations between Staphylococcus aureus genotype, infec-
tion, and in- hospital mortality: a nested case-control study. J
Infect Dis 192:1196–1200
Wiśniewska K, Szewczyk A, Piechowicz L et al (2012) The use of spa
and phage typing for characterization of clinical isolates of
methicillin-resistant Staphylococcus aureus in the University
Clinical Centre in Gdańsk, Poland. Folia Microbiol 57(3):243–249
Witte W, Braulke C, Cuny C et al (2005) Emergence of methicillin-
resistant Staphylococcus aureus with Panton-Valentine leukocidin
in central Europe. Eur J Clin Microbiol Infect Dis 34:1–5
Yacoub A, Lindahl P, Rubin K et al (1994) Purification of bone
sialoprotein-binding protein from Staphylococcus aureus. Eur J
Biochem 222:919–925
471Folia Microbiol (2014) 59:465–471
